NDC 17856-0060-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0060
- Requested NDC
- 17856-0060-01
- Package NDCs from labels
- 17856-0060-1, 17856-0060-3, 17856-0060-2, 17856-0060-4, 17856-0060-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEGESTROL ACETATE ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0060-1 | Megestrol Acetate | 10 mL in 1 CUP | SUSPENSION | 10 | 3 | |
| 17856-0060-2 | Megestrol Acetate | 20 mL in 1 CUP | SUSPENSION | 20 | 3 | |
| 17856-0060-3 | Megestrol Acetate | 72 in 1 BOX | SUSPENSION | 72 | 3 | |
| 17856-0060-4 | Megestrol Acetate | 50 in 1 BOX | SUSPENSION | 50 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0060 | MEGESTROL ACETATE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250524_01119031-9943-4afb-8b45-cb71682f0482.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| DOCUSATE SODIUM | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 5d300ea7-78eb-4e19-8333-1e42c73c4c54 | 2026-02-26 | Warnings | F05Q2T2JA0 |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Advanced Rx LLC | d148be81-79b4-41f7-b8d8-a0e85b661592 | 2026-02-18 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | The Kroger Co. | e1a68bd9-d31a-46a6-8c08-7ad8197b6e0b | 2026-02-13 | Warnings | F05Q2T2JA0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Stool Softener Laxative | DOCUSATE SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | cb2698b1-6c58-417f-ae86-74fbe3814626 | 2026-02-03 | Warnings | F05Q2T2JA0 |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services, LLC | 905bd658-a0af-4f20-be3d-00c54868a26c | 2026-01-29 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Meijer Distribution Inc. | 81edf0d8-b6f3-4b3a-85db-0108160756b1 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1ad73079-ebb3-dae7-e063-6294a90a0558 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.